With industry-leading production facilities which comply with global GMP standards, our pilot labs can develop and optimize the overall small-scale cultivation processes for the selected stable antibody production cell lines, can carry out small-scale to pilot-scale process amplification, and can implement the scale-up production of monoclonal antibodies.